Carbetocin
CAS No. 37025-55-1
Carbetocin( —— )
Catalog No. M20952 CAS No. 37025-55-1
Carbetocin is an obstetric drug used to control postpartum hemorrhage and bleeding after giving birth.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 10MG | 68 | In Stock |
|
| 25MG | 142 | In Stock |
|
| 50MG | 262 | In Stock |
|
| 100MG | 419 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCarbetocin
-
NoteResearch use only, not for human use.
-
Brief DescriptionCarbetocin is an obstetric drug used to control postpartum hemorrhage and bleeding after giving birth.
-
DescriptionCarbetocin is an obstetric drug used to control postpartum hemorrhage and bleeding after giving birth.(In Vitro):Carbetocin is an agonist with about 10-fold lower affinity for the oxytocin receptor but with significantly higher stability and a longer duration of action. Carbetocin has higher affinity to the chimeric E1 receptor and especially to each of the combinations of E1 with the other extracellular domains, i.e. chimeric receptors E13 (Ki=13 nM), E123 (Ki=56 nM), and E1234 (Ki=37 nM).(In Vivo):Carbetocin (2-20 mg/kg; i.p.) has a significant effect of treatment on the percent time spent climbing, swimming and immobile.Carbetocin (1, 10,100 μg/rat, i.c.v.) reveals a dose-dependent increase in the percent time spent swimming and a corresponding reduction in immobility following acute administration of 100 μg/rat.
-
In VitroCarbetocin is an agonist with about 10-fold lower affinity for the oxytocin receptor but with significantly higher stability and a longer duration of action. Carbetocin has higher affinity to the chimeric E1 receptor and especially to each of the combinations of E1 with the other extracellular domains, i.e. chimeric receptors E13 (Ki=13 nM), E123 (Ki=56 nM), and E1234 (Ki=37 nM).
-
In VivoCarbetocin (2-20 mg/kg; i.p.) has a significant effect of treatment on the percent time spent climbing, swimming and immobile. Carbetocin (1, 10,100 μg/rat, i.c.v.) reveals a dose-dependent increase in the percent time spent swimming and a corresponding reduction in immobility following acute administration of 100 μg/rat. Animal Model:Male Sprague-Dawley rats weighing between 300 and 500 g Dosage:2, 6.4, 20 mg/kg Administration:IP; single dose Result:Increased climbing with 6.4 mg/kg and resulted in a significantly greater proportion of time spent swimming with 20 mg/kg.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOxytocin Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number37025-55-1
-
Formula Weight988.16
-
Molecular FormulaC45H69N11O12S
-
Purity>98% (HPLC)
-
SolubilityDMSO:31 mg/mL (31.37 mM)
-
SMILESCC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Theunissen F J Lester C Pujar Y V . Current research on carbetocin and implications for prevention of postpartum haemorrhage[J]. Reproductive Health 2018 15(S1):94-.
molnova catalog
related products
-
2,4-Difluorobenzalde...
2,4-Difluorobenzaldehyde target bont - botulinum neurotoxin type A (Clostridium botulinum).
-
Clemastanin B
Clemastanin B has antioxidant and anti-inflammatory activities, it exerts its anti-influenza activity by inhibiting the virus multiplication, prophylaxsis and blocking the virus attachment.
-
Icariside E4
Icariside E4 is a natural compound derived from Ulmus minor that acts via AMPK phosphorylation and inhibition of MID1IP2 hypolipidation in HepG1 cells.
Cart
sales@molnova.com